SARMA GIVENS: Open Payments
NPI 1356076913 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$190 in 7 payments from 5 companies in 2025. Trend: 2023 $35 · 2024 $0 · 2025 $190
Food & beverage: $190
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 3 | $73 |
| Soleno Therapeutics, Inc. | 1 | $35 |
| Ethicon US, LLC | 1 | $33 |
| ABBVIE INC. | 1 | $31 |
| Novo Nordisk Inc | 1 | $17 |
Products named: GENOTROPIN, VYKAT XR, Enseal X1, LUPRON DEPOT, NGENLA, Sogroya.
Industry payments across MD — which companies pay providers there.
